arrow
R

Richard T. De George

university of texas
H指数:28
被引数:4,669

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

GWTC-4.0: An Introduction to Version 4.0 of the Gravitational-Wave Transient Catalog

GWTC-4.0:引力波暂现源目录4.0版本的介绍

2025-12-090
OA
Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial

抗体介导的LOX-1抑制在心肌梗死后残留炎症患者中的疗效:一项随机第2期临床试验

2025-09-250
PRE
A novel long-acting relaxin-2 fusion, AZD3427, improves cardiac performance in non-human primates with cardiac dysfunction

一种新型的长效松弛素-2融合蛋白AZD3427能够改善心脏功能不全的非人灵长类动物的心脏功能。

2025-03-031
PRE
Comparison of Model-Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia
2025-03-010
OAAI
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy

Evinacumab治疗纯合子家族性高胆固醇血症: 长期安全性和有效性

2024-06-105
OAAI
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia

Evinacumab治疗小儿纯合子家族性高胆固醇血症

2024-01-3021
OAAI
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B
2022-09-2011
OA
Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials A Call to Action From the Heart Failure Collaboratory

改善心力衰竭试验中代表性不足的种族和族裔人群的入学率心力衰竭合作组织的行动呼吁

2022-05-0128
OA
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease
2021-12-018
OA